Table 2.

Clinical Outcomes

Pt.	Etiology	Outcome comments	MRI	Midbrain infarct	LOS, dc	Premorbid mRS	3-mo mRS	12-mo mRS
1	Small vessel		Bilateral thalami	Yes (Unilateral)	15	4	5	5
2	Cardioembolic		Bilateral thalamic	No	2	3	3	3
3	Small vessel		Bilateral thalamic	Yes (bilateral)	5	0	3	3
4	Hypercoagulability of malignancy	EEG monitored, received Narcan	Bilateral thalami, L parietal lobe, R cerebellar	No	6	2	4	4
5	Small vessel		Bilateral thalamus	No	2	0	5	6
6	Cardioembolic		Bilateral thalamic	No	7	1	1
7	Small vessel		Bilateral thalamic	No	10	0	0	1
8	Cardioembolic		Bilateral thalamic	Yes (unilateral)	2	0	4	3
9	Small vessel	Code Stroke (No tPA)	Bilateral thalamus	No	2	0	2
10	Hypercoagulability of malignancy	Received Narcan	Bilateral thalamic	No	20	2	5	2
11	Large vessel atherosclerosis		Bilateral thalamic	Yes (bilateral)	21	0	4
12	Cardioembolic	Received mannitol	Bilat thalami, punctate embolic	Yes (bilateral)	27	5	6	6
13	Large vessel atherosclerosis	Code Stroke (No tPA)	Bilateral thalamus	No	2	4	4	4
14	Cardioembolic	Stroke Code, Received tPA	Bilateral thalamus	No	7	4	3b	4
15	Small vessel		Bilateral thalamus	No	1	0a
Median (IQR)					6c (2.0–12.0)	1.5 (0–3.75)	4 (3.0–4.75)	4 (3.0–4.5)

^aData not included in calculation of median because follow-up mRS was not available.

^bPatient had knee injury at baseline that improved at the 3-mo mark, reducing mRS at that time.

^cLength of stay rounded to the nearest whole days